STEM CELL TREATMENT - AN OVERVIEW

A double-blind, placebo-managed review utilized intravenous allogeneic human MSCs in 53 article-MI patients, with identical adverse occasions involving both of those teams. Ambulatory EKG showed minimized episodes of ventricular tachycardia, and also enhanced pressured expiratory quantity in a single second on pulmonary perform testing while in the